ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $597,000 | -9.5% | 23,150 | +69.9% | 0.01% | -35.7% |
| Q2 2020 | $660,000 | +14.6% | 13,625 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $576,000 | -1.2% | 13,625 | 0.0% | 0.01% | +55.6% |
| Q4 2019 | $583,000 | -51.7% | 13,625 | -59.4% | 0.01% | -43.8% |
| Q3 2019 | $1,207,000 | -34.6% | 33,525 | -51.5% | 0.02% | -33.3% |
| Q2 2019 | $1,846,000 | -26.0% | 69,068 | -25.6% | 0.02% | -27.3% |
| Q1 2019 | $2,494,000 | +197.3% | 92,868 | +79.0% | 0.03% | +153.8% |
| Q4 2018 | $839,000 | -22.1% | 51,868 | 0.0% | 0.01% | -7.1% |
| Q3 2018 | $1,077,000 | +276.6% | 51,868 | +177.4% | 0.01% | +250.0% |
| Q2 2018 | $286,000 | -61.7% | 18,700 | -43.6% | 0.00% | -60.0% |
| Q1 2018 | $746,000 | -20.5% | 33,180 | +6.5% | 0.01% | -9.1% |
| Q4 2017 | $938,000 | -45.0% | 31,160 | -31.2% | 0.01% | -45.0% |
| Q3 2017 | $1,705,000 | -39.2% | 45,260 | -55.0% | 0.02% | -41.2% |
| Q2 2017 | $2,805,000 | -18.4% | 100,560 | +0.6% | 0.03% | -19.0% |
| Q1 2017 | $3,436,000 | +27.7% | 99,950 | +7.2% | 0.04% | +23.5% |
| Q4 2016 | $2,690,000 | -32.4% | 93,275 | -25.5% | 0.03% | -29.2% |
| Q3 2016 | $3,980,000 | -45.5% | 125,125 | -44.3% | 0.05% | +6.7% |
| Q2 2016 | $7,298,000 | +172.9% | 224,800 | +135.0% | 0.04% | +28.6% |
| Q1 2016 | $2,674,000 | +38.9% | 95,650 | +77.2% | 0.04% | +34.6% |
| Q4 2015 | $1,925,000 | +11.4% | 53,990 | +3.3% | 0.03% | +13.0% |
| Q3 2015 | $1,728,000 | -19.2% | 52,240 | +2.4% | 0.02% | -8.0% |
| Q2 2015 | $2,138,000 | +28.8% | 51,040 | +0.2% | 0.02% | +25.0% |
| Q1 2015 | $1,660,000 | +34.7% | 50,940 | +31.3% | 0.02% | +53.8% |
| Q4 2014 | $1,232,000 | +109.2% | 38,800 | +63.0% | 0.01% | +85.7% |
| Q3 2014 | $589,000 | +9.5% | 23,800 | 0.0% | 0.01% | +40.0% |
| Q2 2014 | $538,000 | – | 23,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |